Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion type Assertion NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_head.
- NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion description "[Taken together, these results suggest that targeted delivery of 4-1BBL to the tumor site, when combined with anti-CD3/anti-CD20 diabody, could strongly potentiate the antitumor activity of the diabody, thus may have significant clinical application in the treatment of human CD20-positive B-cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_provenance.
- NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion evidence source_evidence_literature NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_provenance.
- NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion SIO_000772 20463597 NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_provenance.
- NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion wasDerivedFrom befree-20140225 NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_provenance.
- NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_assertion wasGeneratedBy ECO_0000203 NP220484.RAhsu53_PmyG3EXp6IUjGbAigFyy0MwB_a03ajxfi7aAM130_provenance.